In addition, PLAGL1 has been suggested to play a role in numerous cancers, including ovarian, breast and pituitary adenomas, with somatic deletions or gains in methylation resulting in loss of expression of this tumour suppressor gene [30]. This evidence concerns the gene PLAGL1 and cancer.